Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol
Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the...
Saved in:
| Published in | International journal of biological macromolecules Vol. 49; no. 1; pp. 113 - 116 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.07.2011
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0141-8130 1879-0003 1879-0003 |
| DOI | 10.1016/j.ijbiomac.2011.03.007 |
Cover
| Abstract | Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) – haloperidol and the second generation antipsychotic (SGA) – amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol – resveratrol (3,4′,5-trihydroxystilbene, the final concentration – 4μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9×10−6). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. |
|---|---|
| AbstractList | Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) - haloperidol and the second generation antipsychotic (SGA) - amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4 [micro]g/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol - resveratrol (3,4',5-trihydroxystilbene, the final concentration - 4 [micro]g/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p = 7.9 x 10[super]-6). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24 h incubation of plasma with haloperidol compared to the control samples (p 0.01, p 0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24 h) did not cause plasma lipid peroxidation (p 0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) - haloperidol and the second generation antipsychotic (SGA) - amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4 μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol - resveratrol (3,4',5-trihydroxystilbene, the final concentration - 4 μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9 × 10(-6)). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) - haloperidol and the second generation antipsychotic (SGA) - amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4 μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol - resveratrol (3,4',5-trihydroxystilbene, the final concentration - 4 μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9 × 10(-6)). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol.Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) - haloperidol and the second generation antipsychotic (SGA) - amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4 μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol - resveratrol (3,4',5-trihydroxystilbene, the final concentration - 4 μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9 × 10(-6)). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) – haloperidol and the second generation antipsychotic (SGA) – amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol – resveratrol (3,4′,5-trihydroxystilbene, the final concentration – 4μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9×10⁻⁶). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to establish the effects of beta-d-glucan, polysaccharide derived from the yeast cell walls of species such as Saccharomyces cerevisiae, and the antipsychotics (the first generation antipsychotic (FGA) – haloperidol and the second generation antipsychotic (SGA) – amisulpride) action on plasma lipid peroxidation in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with haloperidol or amisulpride in the presence of beta-glucan (4μg/ml). The action of beta-d-glucan was also compared with the properties of a well characterized commercial monomeric polyphenol – resveratrol (3,4′,5-trihydroxystilbene, the final concentration – 4μg/ml). The two-way analysis variance showed that the differences in TBARS levels were depended on the type of tested drugs (p=7.9×10−6). We observed a statistically increase of the level of biomarker of lipid peroxidation such as TBARS after 1 and 24h incubation of plasma with haloperidol compared to the control samples (p<0.01, p<0.02, respectively). Amisulpride, contrary to haloperidol (after 1 and 24h) did not cause plasma lipid peroxidation (p>0.05). We showed that in the presence of beta-glucan, lipid peroxidation in plasma samples treated with haloperidol was significantly decreased. Moreover, we did not observe the synergistic action of beta-glucan and amisulpride on the inhibition of plasma lipid peroxidation. However, the beta-d-glucan was found to be more effective antioxidant, than the solution of pure resveratrol. The presented results indicate that beta-glucan seems to have distinctly protective effects against the impairment of plasma lipid molecules induced by haloperidol. |
| Author | Kontek, Bogdan Rabe-Jabłońska, Jolanta Olas, Beata Dietrich-Muszalska, Anna |
| Author_xml | – sequence: 1 givenname: Anna surname: Dietrich-Muszalska fullname: Dietrich-Muszalska, Anna email: tzn_lodz@post.pl organization: Department of Affective and Psychotic Disorders, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland – sequence: 2 givenname: Beata surname: Olas fullname: Olas, Beata organization: Department of General Biochemistry, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland – sequence: 3 givenname: Bogdan surname: Kontek fullname: Kontek, Bogdan organization: Department of General Biochemistry, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland – sequence: 4 givenname: Jolanta surname: Rabe-Jabłońska fullname: Rabe-Jabłońska, Jolanta organization: Department of Affective and Psychotic Disorders, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21421004$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU9v1DAQxS1URLeFr1Byg0vCOE5sR-IAVPyTKnEoPVsTZ9J6lcTBzlbst8dhuxcO7MnWzO_NaN67YGeTn4ixKw4FBy7fbQu3bZ0f0RYlcF6AKADUM7bhWjU5AIgztgFe8VxzAefsIsZtqsqa6xfsvORVyQGqDWs_0YL5_bCzOGV98GN2i9Y-YPrtLcXMUqBHFx1SFqjbraV5wDhiNrjZddlMwf92HS7OT5mbVqLL2n32gINPPdf54SV73uMQ6dXTe8nuvnz-ef0tv_nx9fv1x5vcVrVaclE2kitR1zX0ogKhSrLAW1mC7SVWDba9shKp0nWPhI3S1ACRhhLTtb0Ul-zNYe4c_K8dxcWMLloaBpzI76LRUgulFBeJfPtfsoTVqqbR5UmUQ6lBScF1Qq-e0F07Umfm4EYMe3M0OwHvD4ANPsZAvbFu-evcEtANaZZZszVbc8zWrNkaECZlm-TyH_lxw0nh64OwR2_wPrho7m4TINOVta6hTsSHA0Epn0dHwUTraEpZukB2MZ13p5b8ASTuyrY |
| CitedBy_id | crossref_primary_10_1016_j_ijbiomac_2021_10_177 crossref_primary_10_1590_s2175_97902019000218312 crossref_primary_10_1097_MED_0b013e3283520fe6 crossref_primary_10_1016_j_ijbiomac_2015_12_014 crossref_primary_10_1155_2022_9565881 crossref_primary_10_1002_jbt_22970 crossref_primary_10_1155_2015_248529 crossref_primary_10_1111_and_13342 crossref_primary_10_1007_s11064_022_03798_4 crossref_primary_10_1016_j_heliyon_2021_e07159 crossref_primary_10_19113_sdufenbed_679568 crossref_primary_10_1016_j_etap_2014_06_011 crossref_primary_10_1002_ptr_8101 crossref_primary_10_1016_j_carbpol_2020_116123 crossref_primary_10_5219_258 crossref_primary_10_1016_j_fct_2020_111782 crossref_primary_10_1080_10520295_2024_2320626 crossref_primary_10_1515_ijfe_2016_0218 crossref_primary_10_1111_are_14529 crossref_primary_10_32900_2312_8402_2023_129_16_25 crossref_primary_10_5187_jast_2023_e123 crossref_primary_10_1111_are_14910 crossref_primary_10_3390_molecules27093037 crossref_primary_10_3390_antiox11071340 |
| Cites_doi | 10.1016/S0006-3223(99)00092-X 10.1016/0006-3223(90)90490-S 10.1080/09537100500128872 10.2165/00023210-200115040-00004 10.1176/jnp.17.2.227 10.1016/S0920-9964(98)00030-9 10.1080/09537100400020591 10.1002/cbf.290020310 10.1016/j.pnpbp.2005.11.009 10.33549/physiolres.930686 10.1001/archsurg.1994.01420350102014 10.1631/jzus.2006.B0981 10.1016/j.plefa.2006.11.003 10.1016/j.euroneuro.2003.09.001 10.3109/09537101003780032 10.1016/j.brainres.2007.06.017 10.1006/abbi.2001.2388 10.1073/pnas.90.17.7915 10.1016/S0049-3848(02)00101-9 10.1016/S0899-9007(03)00036-4 10.3390/medicina43080076 10.1159/000202822 10.1016/S0022-3956(02)00048-1 10.2174/187220807779813938 10.1016/S0140-6736(77)92228-0 10.1016/j.ijbiomac.2011.01.010 10.1080/09537100802641499 10.1093/schbul/15.1.81 10.1016/S0144-8617(98)00099-X 10.3109/15622970902718790 10.1046/j.1471-4159.1998.71031002.x 10.1016/S0013-7006(06)76151-6 10.1016/S0952-3278(96)90143-X 10.1111/j.1440-1819.2010.02132.x 10.1016/j.plefa.2003.08.012 10.1016/j.schres.2005.05.019 10.1016/S0076-6879(99)99016-X 10.1016/S0278-5846(02)00220-8 10.1016/j.jpsychires.2005.10.003 10.1159/000077368 10.1007/s002130100860 10.1016/0006-2952(94)00424-K 10.1016/S1360-1385(97)01018-2 10.1021/jf063209q |
| ContentType | Journal Article |
| Copyright | 2011 Elsevier B.V. Copyright © 2011 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2011 Elsevier B.V. – notice: Copyright © 2011 Elsevier B.V. All rights reserved. |
| DBID | FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM M7N 7S9 L.6 7X8 |
| DOI | 10.1016/j.ijbiomac.2011.03.007 |
| DatabaseName | AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Algology Mycology and Protozoology Abstracts (Microbiology C) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Algology Mycology and Protozoology Abstracts (Microbiology C) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE MEDLINE - Academic AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1879-0003 |
| EndPage | 116 |
| ExternalDocumentID | 21421004 10_1016_j_ijbiomac_2011_03_007 US201600058505 S0141813011000985 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSU SSZ T5K UNMZH ~02 ~G- 29J AAQXK ABFNM ABPIF ABPTK AGRDE AHHHB ASPBG AVWKF AZFZN EJD FBQ FEDTE FGOYB G-2 HLW HVGLF R2- SBG SEW UHS WUQ AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD AGCQF AGRNS CGR CUY CVF ECM EIF NPM SSH M7N 7S9 L.6 7X8 |
| ID | FETCH-LOGICAL-c457t-32961735550f340372ec01b620cf6a49abf7c6ae485faea978e90ee802a003f63 |
| IEDL.DBID | .~1 |
| ISSN | 0141-8130 1879-0003 |
| IngestDate | Thu Sep 25 08:51:15 EDT 2025 Thu Oct 02 09:40:10 EDT 2025 Sat Sep 27 20:05:05 EDT 2025 Mon Jul 21 06:05:35 EDT 2025 Thu Apr 24 23:08:21 EDT 2025 Wed Oct 01 03:09:34 EDT 2025 Wed Dec 27 19:12:10 EST 2023 Fri Feb 23 02:33:35 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Lipid peroxidation Oxidative stress Antipsychotics Haloperidol Beta-glucan |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2011 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c457t-32961735550f340372ec01b620cf6a49abf7c6ae485faea978e90ee802a003f63 |
| Notes | http://dx.doi.org/10.1016/j.ijbiomac.2011.03.007 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
| PMID | 21421004 |
| PQID | 1028076318 |
| PQPubID | 23462 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_868377713 proquest_miscellaneous_2000069982 proquest_miscellaneous_1028076318 pubmed_primary_21421004 crossref_citationtrail_10_1016_j_ijbiomac_2011_03_007 crossref_primary_10_1016_j_ijbiomac_2011_03_007 fao_agris_US201600058505 elsevier_sciencedirect_doi_10_1016_j_ijbiomac_2011_03_007 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-07-01 |
| PublicationDateYYYYMMDD | 2011-07-01 |
| PublicationDate_xml | – month: 07 year: 2011 text: 2011-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | International journal of biological macromolecules |
| PublicationTitleAlternate | Int J Biol Macromol |
| PublicationYear | 2011 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Wachowicz (bib0155) 1984; 2 Dietrich-Muszalska, Olas, Rabe-Jablonska (bib0090) 2005; 16 Fendri, Mechri, Khiari, Othman, Kerkeni, Gaha (bib0185) 2006; 32 Olas, Wachowicz (bib0145) 2002; 106 Olas, Wachowicz (bib0150) 2005; 16 Rice-Evans, Miller, Paganga (bib0165) 1997; 4 Dietrich-Muszalska, Olas (bib0215) 2010; 11 Berstein, Bogerts, Keilhoff (bib0035) 2005; 78 Akyol, Herken, Zu, Fadillioglu Unal, Sogut, Ozyurt, Savas (bib0200) 2002; 26 Pelizon, Kaneno, Soares, Meira, Satori (bib0130) 2005; 54 Silke, Rohn, Kroch, Fleischer, Kurz (bib0235) 2007; 55 Horrobin (bib0195) 1977; 1 Yao, Reddy, Mcelhinny, Van Kammen (bib0020) 1998; 32 Lohr, Kuczenski, Bracha, Moir, Jeste (bib0080) 1990; 28 Saluk-Juszczak, Krolewska, Wachowicz (bib0260) 2011; 48 Parikh, Khan, Mahadik (bib0220) 2003; 37 Jeding, Evans, Akanmu, Dexter, Spencer, Arunoma, Jenner, Halliwell (bib0070) 1995; 49 Müller, Regenbogen, Härtter, Eich, Hiemke (bib0105) 2007; 41 The United States Pharmacopeia Drug Information. 1 (2000). Valko, Leibfritz, Moncol, Cronin, Mazur, Telser (bib0005) 2007; 39 Dietrich-Muszalska (bib0085) 2004; 4 Yao, Reddy, Mcelhinny, Van Kammen (bib0030) 2001; 15 Gama, Salvador, Andreazza, Kapczinski, Silva Belmote-De-Abreu (bib0075) 2006; 30 Li, Chen, Ma, Zhou (bib0040) 2006; 12 Srivastava, Barthwal, Dalal, Agarwal, Nag, Srimal, Seth, Dikshit (bib0025) 2001; 158 Yilmaz, Dulger, Kiymaz, Yilmaz (bib0240) 2007; 1164 Kinnunen, Atalay, Hyyppa, Lehmuskero, Hanninen, Oksala (bib0160) 2005; 4 Ames, Shigenaga, Hagen (bib0170) 1993; 90 Ross (bib0180) 2003; 69 Young, Mckinney, Ross, Wahle, Boyle (bib0055) 2007; 76 Gordon, Brown (bib0110) 2003; 1 Laroche, Michaud (bib0115) 2007; 1 Dakhale, Khanzode, Saoji, Khobragade, Turankar (bib0225) 2004; 49 Soleas, Goldberg (bib0245) 1999; 229 Saluk-Juszczak, Krolewska, Wachowicz (bib0135) 2010; 21 Sagara (bib0205) 1998; 71 Reddy, Yao (bib0015) 1996; 55 Fenton, Hibbeln, Knable (bib0175) 2000; 47 Dietrich-Muszalska, Olas, Glowacki, Bald (bib0060) 2009; 59 Reddy, Yao (bib0190) 1999 Allebeck (bib0010) 1989; 15 Babineau, Hockford, Kenler, Bistrian, Forse, Fairchild (bib0230) 1994; 129 Dietrich-Muszalska, Olas (bib0050) 2009; 20 Stojanovic, Sprintz, Brede (bib0250) 2001; 391 Dietrich-Muszalska, Kontek (bib0065) 2010; 64 Akremiene, Anatolijus, Didziapetriene (bib0125) 2007; 43 Dietrich-Muszalska, Olas (bib0045) 2007; 14 Bergemann, Kopitz, Kress, Frick (bib0100) 2004; 14 Sadula, Kogan, Kacurkova, Machova (bib0120) 1999; 38 Kropp, Kern, Lange, Degner, Hajak, Kornhuber, Ruther, Emrich, Schneider, Bleich (bib0210) 2005; 17 Olas, Wachowicz, Stochmal, Oleszek (bib0255) 2003; 19 Laroche (10.1016/j.ijbiomac.2011.03.007_bib0115) 2007; 1 Bergemann (10.1016/j.ijbiomac.2011.03.007_bib0100) 2004; 14 Müller (10.1016/j.ijbiomac.2011.03.007_bib0105) 2007; 41 Fenton (10.1016/j.ijbiomac.2011.03.007_bib0175) 2000; 47 Silke (10.1016/j.ijbiomac.2011.03.007_bib0235) 2007; 55 Yao (10.1016/j.ijbiomac.2011.03.007_bib0030) 2001; 15 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0065) 2010; 64 Dakhale (10.1016/j.ijbiomac.2011.03.007_bib0225) 2004; 49 Kropp (10.1016/j.ijbiomac.2011.03.007_bib0210) 2005; 17 Lohr (10.1016/j.ijbiomac.2011.03.007_bib0080) 1990; 28 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0215) 2010; 11 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0090) 2005; 16 Sagara (10.1016/j.ijbiomac.2011.03.007_bib0205) 1998; 71 Saluk-Juszczak (10.1016/j.ijbiomac.2011.03.007_bib0135) 2010; 21 Berstein (10.1016/j.ijbiomac.2011.03.007_bib0035) 2005; 78 Olas (10.1016/j.ijbiomac.2011.03.007_bib0145) 2002; 106 Parikh (10.1016/j.ijbiomac.2011.03.007_bib0220) 2003; 37 Fendri (10.1016/j.ijbiomac.2011.03.007_bib0185) 2006; 32 Saluk-Juszczak (10.1016/j.ijbiomac.2011.03.007_bib0260) 2011; 48 Pelizon (10.1016/j.ijbiomac.2011.03.007_bib0130) 2005; 54 Ames (10.1016/j.ijbiomac.2011.03.007_bib0170) 1993; 90 Akyol (10.1016/j.ijbiomac.2011.03.007_bib0200) 2002; 26 Valko (10.1016/j.ijbiomac.2011.03.007_bib0005) 2007; 39 Gama (10.1016/j.ijbiomac.2011.03.007_bib0075) 2006; 30 Ross (10.1016/j.ijbiomac.2011.03.007_bib0180) 2003; 69 Stojanovic (10.1016/j.ijbiomac.2011.03.007_bib0250) 2001; 391 Jeding (10.1016/j.ijbiomac.2011.03.007_bib0070) 1995; 49 Olas (10.1016/j.ijbiomac.2011.03.007_bib0150) 2005; 16 Reddy (10.1016/j.ijbiomac.2011.03.007_bib0015) 1996; 55 Srivastava (10.1016/j.ijbiomac.2011.03.007_bib0025) 2001; 158 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0085) 2004; 4 Olas (10.1016/j.ijbiomac.2011.03.007_bib0255) 2003; 19 Young (10.1016/j.ijbiomac.2011.03.007_bib0055) 2007; 76 Rice-Evans (10.1016/j.ijbiomac.2011.03.007_bib0165) 1997; 4 Soleas (10.1016/j.ijbiomac.2011.03.007_bib0245) 1999; 229 Akremiene (10.1016/j.ijbiomac.2011.03.007_bib0125) 2007; 43 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0045) 2007; 14 Li (10.1016/j.ijbiomac.2011.03.007_bib0040) 2006; 12 Yilmaz (10.1016/j.ijbiomac.2011.03.007_bib0240) 2007; 1164 Yao (10.1016/j.ijbiomac.2011.03.007_bib0020) 1998; 32 Gordon (10.1016/j.ijbiomac.2011.03.007_bib0110) 2003; 1 Sadula (10.1016/j.ijbiomac.2011.03.007_bib0120) 1999; 38 Horrobin (10.1016/j.ijbiomac.2011.03.007_bib0195) 1977; 1 Babineau (10.1016/j.ijbiomac.2011.03.007_bib0230) 1994; 129 Allebeck (10.1016/j.ijbiomac.2011.03.007_bib0010) 1989; 15 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0060) 2009; 59 Kinnunen (10.1016/j.ijbiomac.2011.03.007_bib0160) 2005; 4 Wachowicz (10.1016/j.ijbiomac.2011.03.007_bib0155) 1984; 2 Reddy (10.1016/j.ijbiomac.2011.03.007_bib0190) 1999 Dietrich-Muszalska (10.1016/j.ijbiomac.2011.03.007_bib0050) 2009; 20 10.1016/j.ijbiomac.2011.03.007_bib0095 |
| References_xml | – volume: 12 start-page: 981 year: 2006 end-page: 986 ident: bib0040 publication-title: J. Zhejian Univ. Sci. B – volume: 41 start-page: 673 year: 2007 end-page: 679 ident: bib0105 publication-title: J. Psychiatr. Res. – volume: 39 start-page: 44084 year: 2007 ident: bib0005 publication-title: IJBCB – volume: 32 start-page: 1 year: 1998 end-page: 8 ident: bib0020 publication-title: Schizoph. Res. – volume: 21 start-page: 451 year: 2010 end-page: 459 ident: bib0135 publication-title: Platelets – volume: 229 start-page: 137 year: 1999 end-page: 151 ident: bib0245 publication-title: Methods Enzymol. – volume: 17 start-page: 227 year: 2005 end-page: 231 ident: bib0210 publication-title: J. Neuropsych. – volume: 158 start-page: 140 year: 2001 end-page: 145 ident: bib0025 publication-title: Psychopharmacology – volume: 1 start-page: 59 year: 2007 end-page: 73 ident: bib0115 publication-title: Rec. Pat. Biotechnol. – volume: 4 start-page: 152 year: 1997 end-page: 159 ident: bib0165 publication-title: Trends Plant Sci. – volume: 15 start-page: 287 year: 2001 end-page: 310 ident: bib0030 publication-title: CNS Drugs – volume: 15 start-page: 81 year: 1989 end-page: 89 ident: bib0010 publication-title: Schizophr. Bull. – volume: 49 start-page: 359 year: 1995 end-page: 365 ident: bib0070 publication-title: Biochem. Pharmacol. – volume: 20 start-page: 90 year: 2009 end-page: 96 ident: bib0050 publication-title: Platelets – volume: 43 start-page: 597 year: 2007 end-page: 606 ident: bib0125 publication-title: Medicina – volume: 55 start-page: 33 year: 1996 end-page: 34 ident: bib0015 publication-title: Prostaglandins Leukot. Essent. Fatty Acids – volume: 4 start-page: 215 year: 2004 end-page: 223 ident: bib0085 publication-title: Psychiatria i Psychologia Kliniczna – reference: The United States Pharmacopeia Drug Information. 1 (2000). – start-page: 75 year: 1999 end-page: 88 ident: bib0190 publication-title: Phospholipid Spectrum Disorder in Psychiatry – volume: 49 start-page: 205 year: 2004 end-page: 209 ident: bib0225 publication-title: Neuropsychobiology – volume: 14 start-page: 1 year: 2007 end-page: 6 ident: bib0045 publication-title: World J. Biol. Psychiatry – volume: 55 start-page: 4710 year: 2007 end-page: 4716 ident: bib0235 publication-title: J. Agric. Food Chem. – volume: 1 start-page: 311 year: 2003 end-page: 315 ident: bib0110 publication-title: Immunity – volume: 16 start-page: 251 year: 2005 end-page: 260 ident: bib0150 publication-title: Platelets – volume: 30 start-page: 512 year: 2006 end-page: 515 ident: bib0075 publication-title: Prog. Neuropsychopharmacol. – volume: 16 start-page: 386 year: 2005 end-page: 391 ident: bib0090 publication-title: Platelets – volume: 106 start-page: 143 year: 2002 end-page: 148 ident: bib0145 publication-title: Thromb. Res. – volume: 78 start-page: 69 year: 2005 end-page: 86 ident: bib0035 publication-title: Schizoph. Res. – volume: 64 start-page: 469 year: 2010 end-page: 475 ident: bib0065 publication-title: Psychiatry Clin. Neurosci. – volume: 54 start-page: 557 year: 2005 end-page: 564 ident: bib0130 publication-title: Physiol. Res. – volume: 90 start-page: 7915 year: 1993 end-page: 7922 ident: bib0170 publication-title: Proc. Natl. Acad. Aci. U.S.A. – volume: 28 start-page: 535 year: 1990 end-page: 539 ident: bib0080 publication-title: Biol. Psychiatry – volume: 76 start-page: 73 year: 2007 end-page: 85 ident: bib0055 publication-title: Prostaglandins Leukot. Essent. Fatty Acids – volume: 19 start-page: 633 year: 2003 end-page: 640 ident: bib0255 publication-title: Nutrition – volume: 1 start-page: 936 year: 1977 end-page: 937 ident: bib0195 publication-title: Lancet – volume: 4 start-page: 415 year: 2005 end-page: 421 ident: bib0160 publication-title: J. Sports Sci. Med. – volume: 37 start-page: 43 year: 2003 end-page: 51 ident: bib0220 publication-title: J. Psychiatr. Res. – volume: 11 start-page: 276 year: 2010 end-page: 281 ident: bib0215 publication-title: World J. Biol. Psychiatry – volume: 59 start-page: 1 year: 2009 end-page: 7 ident: bib0060 publication-title: Neuropsychobiology – volume: 14 start-page: 245 year: 2004 end-page: 250 ident: bib0100 publication-title: Eur. Neuropsychopharmacol. – volume: 391 start-page: 79 year: 2001 end-page: 85 ident: bib0250 publication-title: Arch. Biochem. Biophys. – volume: 69 start-page: 407 year: 2003 end-page: 412 ident: bib0180 publication-title: Prostaglandins Leukotr. Essent. Fatty Acids – volume: 2 start-page: 167 year: 1984 end-page: 170 ident: bib0155 publication-title: Cell Biochem. Funct. – volume: 32 start-page: 244 year: 2006 end-page: 252 ident: bib0185 publication-title: Encephale – volume: 129 start-page: 1204 year: 1994 end-page: 1210 ident: bib0230 publication-title: Arch. Surg. – volume: 48 start-page: 488 year: 2011 end-page: 494 ident: bib0260 publication-title: Inter. J. Biol. Macromol. – volume: 1164 start-page: 132 year: 2007 end-page: 135 ident: bib0240 publication-title: Brain Res. – volume: 38 start-page: 247 year: 1999 end-page: 253 ident: bib0120 publication-title: Carbohydr. Polym. – volume: 26 start-page: 995 year: 2002 end-page: 1005 ident: bib0200 publication-title: Progress Neuro-Psychopharmacol. Biol. Psychiatr. – volume: 47 start-page: 8 year: 2000 end-page: 21 ident: bib0175 publication-title: Biol. Psychiatr. – volume: 71 start-page: 1002 year: 1998 end-page: 1012 ident: bib0205 publication-title: J. Neurochem. – volume: 47 start-page: 8 year: 2000 ident: 10.1016/j.ijbiomac.2011.03.007_bib0175 publication-title: Biol. Psychiatr. doi: 10.1016/S0006-3223(99)00092-X – start-page: 75 year: 1999 ident: 10.1016/j.ijbiomac.2011.03.007_bib0190 – volume: 28 start-page: 535 year: 1990 ident: 10.1016/j.ijbiomac.2011.03.007_bib0080 publication-title: Biol. Psychiatry doi: 10.1016/0006-3223(90)90490-S – volume: 16 start-page: 386 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0090 publication-title: Platelets doi: 10.1080/09537100500128872 – volume: 1 start-page: 311 year: 2003 ident: 10.1016/j.ijbiomac.2011.03.007_bib0110 publication-title: Immunity – volume: 15 start-page: 287 year: 2001 ident: 10.1016/j.ijbiomac.2011.03.007_bib0030 publication-title: CNS Drugs doi: 10.2165/00023210-200115040-00004 – volume: 17 start-page: 227 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0210 publication-title: J. Neuropsych. doi: 10.1176/jnp.17.2.227 – volume: 32 start-page: 1 year: 1998 ident: 10.1016/j.ijbiomac.2011.03.007_bib0020 publication-title: Schizoph. Res. doi: 10.1016/S0920-9964(98)00030-9 – volume: 16 start-page: 251 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0150 publication-title: Platelets doi: 10.1080/09537100400020591 – volume: 2 start-page: 167 year: 1984 ident: 10.1016/j.ijbiomac.2011.03.007_bib0155 publication-title: Cell Biochem. Funct. doi: 10.1002/cbf.290020310 – volume: 30 start-page: 512 year: 2006 ident: 10.1016/j.ijbiomac.2011.03.007_bib0075 publication-title: Prog. Neuropsychopharmacol. doi: 10.1016/j.pnpbp.2005.11.009 – volume: 54 start-page: 557 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0130 publication-title: Physiol. Res. doi: 10.33549/physiolres.930686 – volume: 129 start-page: 1204 year: 1994 ident: 10.1016/j.ijbiomac.2011.03.007_bib0230 publication-title: Arch. Surg. doi: 10.1001/archsurg.1994.01420350102014 – volume: 12 start-page: 981 year: 2006 ident: 10.1016/j.ijbiomac.2011.03.007_bib0040 publication-title: J. Zhejian Univ. Sci. B doi: 10.1631/jzus.2006.B0981 – volume: 76 start-page: 73 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0055 publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/j.plefa.2006.11.003 – volume: 14 start-page: 245 year: 2004 ident: 10.1016/j.ijbiomac.2011.03.007_bib0100 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2003.09.001 – volume: 21 start-page: 451 year: 2010 ident: 10.1016/j.ijbiomac.2011.03.007_bib0135 publication-title: Platelets doi: 10.3109/09537101003780032 – volume: 1164 start-page: 132 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0240 publication-title: Brain Res. doi: 10.1016/j.brainres.2007.06.017 – volume: 391 start-page: 79 year: 2001 ident: 10.1016/j.ijbiomac.2011.03.007_bib0250 publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.2001.2388 – volume: 90 start-page: 7915 year: 1993 ident: 10.1016/j.ijbiomac.2011.03.007_bib0170 publication-title: Proc. Natl. Acad. Aci. U.S.A. doi: 10.1073/pnas.90.17.7915 – volume: 106 start-page: 143 year: 2002 ident: 10.1016/j.ijbiomac.2011.03.007_bib0145 publication-title: Thromb. Res. doi: 10.1016/S0049-3848(02)00101-9 – volume: 39 start-page: 44084 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0005 publication-title: IJBCB – volume: 19 start-page: 633 year: 2003 ident: 10.1016/j.ijbiomac.2011.03.007_bib0255 publication-title: Nutrition doi: 10.1016/S0899-9007(03)00036-4 – volume: 43 start-page: 597 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0125 publication-title: Medicina doi: 10.3390/medicina43080076 – volume: 59 start-page: 1 year: 2009 ident: 10.1016/j.ijbiomac.2011.03.007_bib0060 publication-title: Neuropsychobiology doi: 10.1159/000202822 – volume: 37 start-page: 43 year: 2003 ident: 10.1016/j.ijbiomac.2011.03.007_bib0220 publication-title: J. Psychiatr. Res. doi: 10.1016/S0022-3956(02)00048-1 – ident: 10.1016/j.ijbiomac.2011.03.007_bib0095 – volume: 4 start-page: 415 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0160 publication-title: J. Sports Sci. Med. – volume: 1 start-page: 59 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0115 publication-title: Rec. Pat. Biotechnol. doi: 10.2174/187220807779813938 – volume: 1 start-page: 936 year: 1977 ident: 10.1016/j.ijbiomac.2011.03.007_bib0195 publication-title: Lancet doi: 10.1016/S0140-6736(77)92228-0 – volume: 48 start-page: 488 year: 2011 ident: 10.1016/j.ijbiomac.2011.03.007_bib0260 publication-title: Inter. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2011.01.010 – volume: 20 start-page: 90 year: 2009 ident: 10.1016/j.ijbiomac.2011.03.007_bib0050 publication-title: Platelets doi: 10.1080/09537100802641499 – volume: 15 start-page: 81 year: 1989 ident: 10.1016/j.ijbiomac.2011.03.007_bib0010 publication-title: Schizophr. Bull. doi: 10.1093/schbul/15.1.81 – volume: 38 start-page: 247 year: 1999 ident: 10.1016/j.ijbiomac.2011.03.007_bib0120 publication-title: Carbohydr. Polym. doi: 10.1016/S0144-8617(98)00099-X – volume: 11 start-page: 276 year: 2010 ident: 10.1016/j.ijbiomac.2011.03.007_bib0215 publication-title: World J. Biol. Psychiatry doi: 10.3109/15622970902718790 – volume: 71 start-page: 1002 year: 1998 ident: 10.1016/j.ijbiomac.2011.03.007_bib0205 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1998.71031002.x – volume: 32 start-page: 244 year: 2006 ident: 10.1016/j.ijbiomac.2011.03.007_bib0185 publication-title: Encephale doi: 10.1016/S0013-7006(06)76151-6 – volume: 55 start-page: 33 year: 1996 ident: 10.1016/j.ijbiomac.2011.03.007_bib0015 publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/S0952-3278(96)90143-X – volume: 64 start-page: 469 year: 2010 ident: 10.1016/j.ijbiomac.2011.03.007_bib0065 publication-title: Psychiatry Clin. Neurosci. doi: 10.1111/j.1440-1819.2010.02132.x – volume: 69 start-page: 407 year: 2003 ident: 10.1016/j.ijbiomac.2011.03.007_bib0180 publication-title: Prostaglandins Leukotr. Essent. Fatty Acids doi: 10.1016/j.plefa.2003.08.012 – volume: 78 start-page: 69 year: 2005 ident: 10.1016/j.ijbiomac.2011.03.007_bib0035 publication-title: Schizoph. Res. doi: 10.1016/j.schres.2005.05.019 – volume: 229 start-page: 137 year: 1999 ident: 10.1016/j.ijbiomac.2011.03.007_bib0245 publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(99)99016-X – volume: 26 start-page: 995 year: 2002 ident: 10.1016/j.ijbiomac.2011.03.007_bib0200 publication-title: Progress Neuro-Psychopharmacol. Biol. Psychiatr. doi: 10.1016/S0278-5846(02)00220-8 – volume: 41 start-page: 673 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0105 publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2005.10.003 – volume: 4 start-page: 215 year: 2004 ident: 10.1016/j.ijbiomac.2011.03.007_bib0085 publication-title: Psychiatria i Psychologia Kliniczna – volume: 49 start-page: 205 year: 2004 ident: 10.1016/j.ijbiomac.2011.03.007_bib0225 publication-title: Neuropsychobiology doi: 10.1159/000077368 – volume: 158 start-page: 140 year: 2001 ident: 10.1016/j.ijbiomac.2011.03.007_bib0025 publication-title: Psychopharmacology doi: 10.1007/s002130100860 – volume: 14 start-page: 1 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0045 publication-title: World J. Biol. Psychiatry – volume: 49 start-page: 359 year: 1995 ident: 10.1016/j.ijbiomac.2011.03.007_bib0070 publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(94)00424-K – volume: 4 start-page: 152 year: 1997 ident: 10.1016/j.ijbiomac.2011.03.007_bib0165 publication-title: Trends Plant Sci. doi: 10.1016/S1360-1385(97)01018-2 – volume: 55 start-page: 4710 year: 2007 ident: 10.1016/j.ijbiomac.2011.03.007_bib0235 publication-title: J. Agric. Food Chem. doi: 10.1021/jf063209q |
| SSID | ssj0006518 |
| Score | 2.0770657 |
| Snippet | Since oxidative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics, the aim of the study was to... |
| SourceID | proquest pubmed crossref fao elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 113 |
| SubjectTerms | Adult Analysis of Variance Antioxidants Antipsychotic Agents - adverse effects Antipsychotic Agents - metabolism Antipsychotics Beta-glucan beta-glucans beta-Glucans - metabolism beta-Glucans - pharmacology biomarkers blood lipids Cell walls Drugs Female Haloperidol Haloperidol - adverse effects Haloperidol - metabolism Humans Lipid peroxidation Lipid Peroxidation - drug effects Macromolecules Male Mental disorders Neuroleptics Oxidative stress patients Polyphenols Polysaccharides protective effect Resveratrol Saccharomyces cerevisiae Saccharomyces cerevisiae - chemistry Schizophrenia Schizophrenia - drug therapy Sulpiride - adverse effects Sulpiride - analogs & derivatives Sulpiride - metabolism synergism thiobarbituric acid Thiobarbituric Acid Reactive Substances - analysis thiobarbituric acid-reactive substances yeasts |
| Title | Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol |
| URI | https://dx.doi.org/10.1016/j.ijbiomac.2011.03.007 https://www.ncbi.nlm.nih.gov/pubmed/21421004 https://www.proquest.com/docview/1028076318 https://www.proquest.com/docview/2000069982 https://www.proquest.com/docview/868377713 |
| Volume | 49 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-0003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006518 issn: 0141-8130 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection customDbUrl: eissn: 1879-0003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006518 issn: 0141-8130 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1879-0003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006518 issn: 0141-8130 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect (Elsevier) customDbUrl: eissn: 1879-0003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006518 issn: 0141-8130 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-0003 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006518 issn: 0141-8130 databaseCode: AKRWK dateStart: 19790401 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKOcAF8W54VEbimq4TO3Z8LCuqBUQvZaXerLHjQFbbZNVuJXrhtzOTR4HDqgdukTWW4hl75nMy8w1j72VUKiIOThXICi8otU29VUXqjayD0N6oguqdv57qxVJ9Pi_O99h8qoWhtMrR9w8-vffW48hs1OZs0zQzSkvC8CR70jNhSyo0V8pQF4OjX3_SPHTRf-Mj4ZSk_6oSXh01KypyhzBSeRLZqdkVoO7V0O2GoX04OnnMHo04kh8Pr_qE7cX2KXswn9q3PWP-Q9xCn5EOLaciEn4GgWqsuosb9A089Am-Vw1Efkn0rTi0QSR9AXzdbJqKE4H4z2bouMTx4o4SFfc3_AesO2JHrrr1c7Y8-fhtvkjHhgppUIXZpjK3CFgQYRSilkpIk8cgMq9zEWoNyoKvTdAQVVnUEAEvmNGKGEuRAx7-WssXbL_t2njAONW0ZlBpHywimApsnWkQUvVPXqqEFZMWXRjZxqnpxdpNaWUrN2nfkfadkA61n7DZ7bzNwLdx5ww7Gcn9s3McBoU75x6gVR18R4fqlmc50e1Ro0WEhQl7N5naoeXoNwq0sbu-cgTJBLrlrNwtk_c4AK-yecL4DplSl9IYk8mEvRy20u2KiQePqPxe_cfaXrOHw_dvSi1-w_a3l9fxLQKorT_sT8ghu3_86cvi9DfjJBiT |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbacigXxLuBAkbimq4TO3ZypCuqBdpe2pV6s8aOQ7PaJqt2K9ELv52ZPAocVj1wi6yxFM_Y42-SmW8Y-ySDUgFxcKxAlhigVEXsCpXFzsjKC-2Myqje-eRUz-bq20V2scWmYy0MpVUOvr_36Z23HkYmgzYnq7qeUFoSXk-yIz0TRZ5ts0cqSw1FYAe__uR56Kz7yEfSMYn_VSa8OKgXVOUOfuDyJLZTs-mG2q6g3YxDu_vo6Cl7MgBJ_rl_12dsKzTP2e507N_2grnDsIYuJR0aTlUk_Aw8FVm1V3foHLjvMnxvagj8mvhbcWiFUPoK-LJe1SUnBvGfdd9yiWPkjhIld3f8EpYt0SOX7fIlmx99OZ_O4qGjQuxVZtaxTAtELAgxMlFJJaRJgxeJ06nwlQZVgKuM1xBUnlUQACPMUIgQcpECnv5Ky1dsp2mbsMc4FbUmUGrnC4QwJRRVokFI1T05qSKWjVq0fqAbp64XSzvmlS3sqH1L2rdCWtR-xCb381Y94caDM4rRSPafrWPxVnhw7h5a1cIP9Kh2fpYS3x51WkRcGLGPo6ktWo7-o0AT2tsbS5hMoF9O8s0yaQcEMJZNI8Y3yOQ6l8aYREbsdb-V7ldMRHjE5ffmP9b2ge3Ozk-O7fHX0-9v2eP-YzjlGe-znfX1bXiHaGrt3nen5Tc1rhoo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beta-glucan+from+Saccharomyces+cerevisiae+reduces+plasma+lipid+peroxidation+induced+by+haloperidol&rft.jtitle=International+journal+of+biological+macromolecules&rft.au=Dietrich-Muszalska%2C+Anna&rft.au=Olas%2C+Beata&rft.au=Kontek%2C+Bogdan&rft.au=Rabe-Jab%C5%82o%C5%84ska%2C+Jolanta&rft.date=2011-07-01&rft.issn=1879-0003&rft.eissn=1879-0003&rft.volume=49&rft.issue=1&rft.spage=113&rft_id=info:doi/10.1016%2Fj.ijbiomac.2011.03.007&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0141-8130&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0141-8130&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0141-8130&client=summon |